Targeting Asymptomatic Bacteriuria in Antimicrobial Stewardship: the Role of the Microbiology Laboratory

被引:14
|
作者
Wiley, Zanthia [1 ]
Jacob, Jesse T. [1 ]
Burd, Eileen M. [1 ,2 ]
机构
[1] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
asymptomatic; asymptomatic bacteriuria; bacteriuria; urine culture; INFECTIOUS-DISEASES SOCIETY; CLINICAL-PRACTICE GUIDELINE; OVERTREATMENT; PREVALENCE; MANAGEMENT; CULTURE; UPDATE; MEN;
D O I
10.1128/JCM.00518-18
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This minireview focuses on the microbiologic evaluation of patients with asymptomatic bacteriuria, as well as indications for antibiotic treatment. Asymptomatic bacteriuria is defined as two consecutive voided specimens (preferably within 2 weeks) with the same bacterial species, isolated in quantitative counts of >= 10(5) CFU/ml in women, including pregnant women; a single voided urine specimen with one bacterial species isolated in a quantitative count >= 10(5) CFU/ml in men; and a single catheterized urine specimen with one or more bacterial species isolated in a quantitative count of >10(5) CFU/ml in either women or men (or >10(2) CFU/ml of a single bacterial species from a single catheterized urine specimen). Any urine specimen with >= 10(4) CFU/ml group B Streptococcus is significant for asymptomatic bacteriuria in a pregnant woman. Asymptomatic bacteriuria occurs, irrespective of pyuria, in the absence of signs or symptoms of a urinary tract infection. The two groups with the best evidence of adverse outcomes in the setting of untreated asymptomatic bacteriuria include pregnant women and patients who undergo urologic procedures with risk of mucosal injury. Screening and treatment of asymptomatic bacteriuria is not recommended in the following patient populations: pediatric patients, healthy nonpregnant women, older patients in the inpatient or outpatient setting, diabetic patients, patients with an indwelling urethral catheter, patients with impaired voiding following spinal cord injury, patients undergoing nonurologic surgeries, and nonrenal solid-organ transplant recipients. Renal transplant recipients beyond 1 month posttransplant should not undergo screening and treatment for asymptomatic bacteriuria. There is insufficient evidence to recommend for or against screening of renal transplant recipients within 1 month, patients with high-risk neutropenia, or patients with indwelling catheters at the time of catheter removal. Unwarranted antibiotics place patients at increased risk of adverse effects (including Clostridioides difficile diarrhea) and contribute to antibiotic resistance. Methods to reduce unnecessary screening for and treatment of asymptomatic bacteriuria aid in antibiotic stewardship.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The Role of the Microbiology Laboratory in Antimicrobial Stewardship Programs
    Avdic, Edina
    Carroll, Karen C.
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2014, 28 (02) : 215 - +
  • [2] Role of the Clinical Microbiology Laboratory in Antimicrobial Stewardship
    Bouza, Emilio
    Munoz, Patricia
    Burillo, Almudena
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2018, 102 (05) : 883 - +
  • [3] Impact of Antimicrobial Stewardship Interventions on Antimicrobial Utilization in Asymptomatic Bacteriuria
    Shah, Punit J.
    Ike, Chiamaka
    Thibeaux, Meghan
    Rodriguez, Emilyn
    Maddox, Shermel-Edwards
    Daoura, Nicolas
    [J]. HOSPITAL PHARMACY, 2021, 56 (04) : 210 - 214
  • [4] The Role of Antimicrobial Stewardship in the Clinical Microbiology Laboratory: Stepping Up to the Plate
    MacVane, Shawn H.
    Hurst, John M.
    Steed, Lisa L.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (04):
  • [5] Teamwork and safety climate affect antimicrobial stewardship for asymptomatic bacteriuria
    Drekonja, Dimitri M.
    Grigoryan, Larissa
    Lichtenberger, Paola
    Graber, Christopher J.
    Patel, Payal K.
    Van, John N.
    Dillon, Laura M.
    Wang, Yiqun
    Gauthier, Timothy P.
    Wiseman, Steve W.
    Shukla, Bhavarth S.
    Naik, Aanand D.
    Hysong, Sylvia J.
    Kramer, Jennifer R.
    Trautner, Barbara W.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2019, 40 (09): : 963 - 967
  • [6] Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship
    Morency-Potvin, Philippe
    Schwartz, David N.
    Weinstein, Robert A.
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2017, 30 (01) : 381 - 407
  • [7] Evaluation of an Antimicrobial Stewardship Approach to Minimize Overuse of Antibiotics in Patients with Asymptomatic Bacteriuria
    Kelley, Denise
    Aaronson, Patrick
    Poon, Elaine
    McCarter, Yvette S.
    Bato, Ben
    Jankowski, Christopher A.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (02): : 193 - 195
  • [8] Effectiveness of an Antimicrobial Stewardship Approach for Urinary Catheter-Associated Asymptomatic Bacteriuria
    Trautner, Barbara W.
    Grigoryan, Larissa
    Petersen, Nancy J.
    Hysong, Sylvia
    Cadena, Jose
    Patterson, Jan E.
    Naik, Aanand D.
    [J]. JAMA INTERNAL MEDICINE, 2015, 175 (07) : 1120 - 1127
  • [9] The role of the microbiology laboratory in antimicrobial susceptibility testing
    Washington, JA
    [J]. INFECTIONS IN MEDICINE, 1999, 16 (08) : 531 - 532
  • [10] Eliciting Clinician Perspectives on Asymptomatic Bacteriuria to Identify Targets for Antimicrobial Stewardship Education and Decision Support
    Durkin, Michael J.
    Schmitz, Viktoria
    Hsueh, Kevin
    Ney, Katheryn
    Politi, Mary C.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (08):